Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorLahey Clinic
About this trial
The purpose of this study is to determine if analysis of DNA and protein material found in urine will be useful in the detection of urothelial cancer of the bladder and kidney. This analysis may be helpful to determine if how a particular cancer will act regarding remission and recurrence
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients scheduled to have a nephroureterectomy, cystectomy, cytoscopy (newly diagnosed bladder cancer and those with recurrent disease in follow up)
Control Group: No known evidence of bladder cancer-one urine sample
> than 18 years of age
Disqualifiers
< than 18 years of age
Trial population
Lahey Clinic patients presenting to the Department of Urology and Primary Care Referrals
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 2 trial groupsGroup A: 1
Group B: 2
Trial outcomes
Primary outcomes
1
To evaluate the utility of emerging technologies in the detection of bladder tumor cells using non-invasive approaches utilizing voided urine samples.
Time frame
Ongoing Lab analysis for study duration: final data completion dateSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov